<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=6796&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="431389" class="table-">
                
                <td>Sept. 23, 2022, 4 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 6, &quot;treatment_name&quot;: &quot;Abatacept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 181, &quot;treatment_name&quot;: &quot;Baricitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Canakinumab Injection&quot;, &quot;treatment_type&quot;: &quot;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 696, &quot;treatment_name&quot;: &quot;Ixekizumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1177, &quot;treatment_name&quot;: &quot;Secukinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TNF Inhibitor&quot;, &quot;treatment_type&quot;: &quot;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1300, &quot;treatment_name&quot;: &quot;Tofacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1998, &quot;treatment_name&quot;: &quot;Upadacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 6, &quot;treatment_name&quot;: &quot;Abatacept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 181, &quot;treatment_name&quot;: &quot;Baricitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 247, &quot;treatment_name&quot;: &quot;Canakinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 696, &quot;treatment_name&quot;: &quot;Ixekizumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1177, &quot;treatment_name&quot;: &quot;Secukinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}, {&quot;arm_notes&quot;: &quot;or Certolizumab, Golimumab, Adalimumab&quot;, &quot;treatment_id&quot;: 483, &quot;treatment_name&quot;: &quot;Etanercept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1300, &quot;treatment_name&quot;: &quot;Tofacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1998, &quot;treatment_name&quot;: &quot;Upadacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="144486" class="table-">
                
                <td>Oct. 16, 2021, 3 p.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 6, &quot;treatment_name&quot;: &quot;Abatacept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Canakinumab Injection&quot;, &quot;treatment_type&quot;: &quot;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1177, &quot;treatment_name&quot;: &quot;Secukinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TNF Inhibitor&quot;, &quot;treatment_type&quot;: &quot;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1300, &quot;treatment_name&quot;: &quot;Tofacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1998, &quot;treatment_name&quot;: &quot;Upadacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;Hold SQ ABA x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 6, &quot;treatment_name&quot;: &quot;Abatacept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Hold CAN TNFi x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 247, &quot;treatment_name&quot;: &quot;Canakinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Hold SEC x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 1177, &quot;treatment_name&quot;: &quot;Secukinumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Hold UPA x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 1998, &quot;treatment_name&quot;: &quot;Upadacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Hold SQ TNFi x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 483, &quot;treatment_name&quot;: &quot;Etanercept&quot;, &quot;treatment_type&quot;: &quot;Immunosuppressants&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Hold TOF x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 1300, &quot;treatment_name&quot;: &quot;Tofacitinib&quot;, &quot;treatment_type&quot;: &quot;Kinase inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;Treatment Continuation of All Immunomodulatory Therapy at the time of COVID Vaccine Booster (mRNA vaccine dose #3);(completed 2-dose regime of mRNA COVID-19 vaccine (&gt;28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))&quot;, &quot;treatment_id&quot;: 2188, &quot;treatment_name&quot;: &quot;Standard of care&quot;, &quot;treatment_type&quot;: &quot;Standard of care&quot;, &quot;pharmacological_treatment&quot;: &quot;Standard of care&quot;}]
        </p>
        
    
                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
Sept. 23, 2022, 4 a.m.	usa	[{"arm_notes": "nan", "treatment_id": 6, "treatment_name": "Abatacept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 181, "treatment_name": "Baricitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Canakinumab Injection", "treatment_type": "Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 696, "treatment_name": "Ixekizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1177, "treatment_name": "Secukinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "TNF Inhibitor", "treatment_type": "Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1998, "treatment_name": "Upadacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]	[{"arm_notes": "", "treatment_id": 6, "treatment_name": "Abatacept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 181, "treatment_name": "Baricitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 247, "treatment_name": "Canakinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 696, "treatment_name": "Ixekizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1177, "treatment_name": "Secukinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "or Certolizumab, Golimumab, Adalimumab", "treatment_id": 483, "treatment_name": "Etanercept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1998, "treatment_name": "Upadacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]
Oct. 16, 2021, 3 p.m.	usa	[{"arm_notes": "nan", "treatment_id": 6, "treatment_name": "Abatacept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Canakinumab Injection", "treatment_type": "Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1177, "treatment_name": "Secukinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "TNF Inhibitor", "treatment_type": "Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1998, "treatment_name": "Upadacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]	[{"arm_notes": "Hold SQ ABA x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 6, "treatment_name": "Abatacept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Hold CAN TNFi x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 247, "treatment_name": "Canakinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Hold SEC x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 1177, "treatment_name": "Secukinumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Hold UPA x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 1998, "treatment_name": "Upadacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Hold SQ TNFi x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 483, "treatment_name": "Etanercept", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Hold TOF x 2 weeks at time of COVID booster;(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Treatment Continuation of All Immunomodulatory Therapy at the time of COVID Vaccine Booster (mRNA vaccine dose #3);(completed 2-dose regime of mRNA COVID-19 vaccine (>28 days prior) and who are planning to receive an additional dose of mRNA COVID-19 vaccine (i.e., booster))", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]